ReP USP - Resultado da busca

Artigo de periodico
High levels of metals/metalloids in blood and urine of residents living in the area affected by the dam failing in Barra Longa, District, Brazil: a preliminary human biomonitoring study (2021)
Vormittag, Evangelina; Saldiva, Paulo Hilário Nascimento ; Anastacio, Andressa Vilas Boas; Barbosa Júnior, Fernando
Source: Environmental Toxicology and Pharmacology. Unidades: FCFRP, FM
Subjects: ACIDENTES DE TRABALHO, ARSÊNIO, MONITORAMENTO BIOLÓGICO, POLUIÇÃO AMBIENTAL, RESÍDUOS INDUSTRIAIS, METAIS, MINERAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VORMITTAG, Evangelina et al. High levels of metals/metalloids in blood and urine of residents living in the area affected by the dam failing in Barra Longa, District, Brazil: a preliminary human biomonitoring study. Environmental Toxicology and Pharmacology, v. 83, p. 1-5, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.etap.2020.103566. Acesso em: 16 nov. 2024.
APA
Vormittag, E., Saldiva, P. H. N., Anastacio, A. V. B., & Barbosa Júnior, F. (2021). High levels of metals/metalloids in blood and urine of residents living in the area affected by the dam failing in Barra Longa, District, Brazil: a preliminary human biomonitoring study. Environmental Toxicology and Pharmacology, 83, 1-5. doi:10.1016/j.etap.2020.103566
NLM
Vormittag E, Saldiva PHN, Anastacio AVB, Barbosa Júnior F. High levels of metals/metalloids in blood and urine of residents living in the area affected by the dam failing in Barra Longa, District, Brazil: a preliminary human biomonitoring study [Internet]. Environmental Toxicology and Pharmacology. 2021 ; 83 1-5.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.etap.2020.103566
Vancouver
Vormittag E, Saldiva PHN, Anastacio AVB, Barbosa Júnior F. High levels of metals/metalloids in blood and urine of residents living in the area affected by the dam failing in Barra Longa, District, Brazil: a preliminary human biomonitoring study [Internet]. Environmental Toxicology and Pharmacology. 2021 ; 83 1-5.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.etap.2020.103566
Artigo de periodico
Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review (2021)
Dantas, Naiara Castelo Branco; Braz, Adriana F.; Malaquias, Alexsandra; Lemos-Marini, Sofia; Arnhold, Ivo Jorge Prado ; Ramos, Ester Silveira; Antonini, Sonir Roberto Rauber ; Guerra-Junior, Gil; Mendonça, Berenice Bilharinho de; Jorge, Alexander Augusto de Lima ; Scalco, Renata C.
Source: Hormone Research in Paediatrics. Unidades: FM, FMRP
Subjects: HORMÔNIO DO CRESCIMENTO, ADULTOS, HORMÔNIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DANTAS, Naiara Castelo Branco et al. Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review. Hormone Research in Paediatrics, v. 94, n. 1-2, p. 63-70, 2021Tradução . . Disponível em: https://doi.org/10.1159/000516869. Acesso em: 16 nov. 2024.
APA
Dantas, N. C. B., Braz, A. F., Malaquias, A., Lemos-Marini, S., Arnhold, I. J. P., Ramos, E. S., et al. (2021). Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review. Hormone Research in Paediatrics, 94( 1-2), 63-70. doi:10.1159/000516869
NLM
Dantas NCB, Braz AF, Malaquias A, Lemos-Marini S, Arnhold IJP, Ramos ES, Antonini SRR, Guerra-Junior G, Mendonça BB de, Jorge AA de L, Scalco RC. Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review [Internet]. Hormone Research in Paediatrics. 2021 ; 94( 1-2): 63-70.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1159/000516869
Vancouver
Dantas NCB, Braz AF, Malaquias A, Lemos-Marini S, Arnhold IJP, Ramos ES, Antonini SRR, Guerra-Junior G, Mendonça BB de, Jorge AA de L, Scalco RC. Adult height in 299 patients with Turner syndrome with or without growth hormone therapy: results and literature review [Internet]. Hormone Research in Paediatrics. 2021 ; 94( 1-2): 63-70.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1159/000516869
Artigo de periodico
Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia (2021)
Padovani, Karina Stringhetta; Goto, Renata Nishida; Fugio, Lais Brigliadori; Garcia, Cristiana Bernadelli ; Alves, Vani Maria; Brassesco, Maria Sol ; Greene, Lewis Joel; Rego, Eduardo Magalhães; Leopoldino, Andréia Machado
Source: FEBS Open Bio. Unidades: FCFRP, FMRP, FFCLRP, FM
Subjects: LEUCEMIA, EXPRESSÃO GÊNICA, TRANSCRIÇÃO GÊNICA, CÉLULAS DA MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PADOVANI, Karina Stringhetta et al. Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia. FEBS Open Bio, v. 11, n. 7, p. 2019-2032, 2021Tradução . . Disponível em: https://doi.org/10.1002/2211-5463.13210. Acesso em: 16 nov. 2024.
APA
Padovani, K. S., Goto, R. N., Fugio, L. B., Garcia, C. B., Alves, V. M., Brassesco, M. S., et al. (2021). Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia. FEBS Open Bio, 11( 7), 2019-2032. doi:10.1002/2211-5463.13210
NLM
Padovani KS, Goto RN, Fugio LB, Garcia CB, Alves VM, Brassesco MS, Greene LJ, Rego EM, Leopoldino AM. Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia [Internet]. FEBS Open Bio. 2021 ; 11( 7): 2019-2032.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/2211-5463.13210
Vancouver
Padovani KS, Goto RN, Fugio LB, Garcia CB, Alves VM, Brassesco MS, Greene LJ, Rego EM, Leopoldino AM. Crosstalk between hnRNP K and SET in ATRA‐induced differentiation in acute promyelocytic leukemia [Internet]. FEBS Open Bio. 2021 ; 11( 7): 2019-2032.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/2211-5463.13210
Artigo de periodico
Induction therapeutic drug monitoring regimen with infliximab: a simplified evidence-based algorithm for inflammatory bowel disease (2020)
Queiroz, Natalia Sousa Freitas; Teixeira, Fábio Vieira; Parra, Rogério Serafim; Kotze, Paulo Gustavo
Source: Arquivos de Gastroenterologia. Unidades: FM, FMRP
Subjects: ALGORITMOS, FÁRMACOS GASTRINTESTINAIS, ENTEROPATIAS INFLAMATÓRIAS, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
QUEIROZ, Natalia Sousa Freitas et al. Induction therapeutic drug monitoring regimen with infliximab: a simplified evidence-based algorithm for inflammatory bowel disease. Arquivos de Gastroenterologia, v. 57, n. 4, p. 507-510, 2020Tradução . . Disponível em: https://doi.org/10.1590/S0004-2803.202000000-76. Acesso em: 16 nov. 2024.
APA
Queiroz, N. S. F., Teixeira, F. V., Parra, R. S., & Kotze, P. G. (2020). Induction therapeutic drug monitoring regimen with infliximab: a simplified evidence-based algorithm for inflammatory bowel disease. Arquivos de Gastroenterologia, 57( 4), 507-510. doi:10.1590/S0004-2803.202000000-76
NLM
Queiroz NSF, Teixeira FV, Parra RS, Kotze PG. Induction therapeutic drug monitoring regimen with infliximab: a simplified evidence-based algorithm for inflammatory bowel disease [Internet]. Arquivos de Gastroenterologia. 2020 ; 57( 4): 507-510.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/S0004-2803.202000000-76
Vancouver
Queiroz NSF, Teixeira FV, Parra RS, Kotze PG. Induction therapeutic drug monitoring regimen with infliximab: a simplified evidence-based algorithm for inflammatory bowel disease [Internet]. Arquivos de Gastroenterologia. 2020 ; 57( 4): 507-510.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1590/S0004-2803.202000000-76
Artigo de periodico
Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial (2017)
Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Bahit, M. Cecilia; Ardissino, Diego; Bueno, Héctor; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Róbert Gábor; Güray, Ümit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael
Source: Lancet. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ANTICOAGULANTES, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OHMAN, E. Magnus et al. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, v. 389, n. 10081, p. 1799-1808, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30751-1. Acesso em: 16 nov. 2024.
APA
Ohman, E. M., Roe, M. T., Steg, P. G., James, S. K., Povsic, T. J., White, J., et al. (2017). Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. Lancet, 389( 10081), 1799-1808. doi:10.1016/S0140-6736(17)30751-1
NLM
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Vancouver
Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D-W, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial [Internet]. Lancet. 2017 ; 389( 10081): 1799-1808.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)30751-1
Artigo de periodico
PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia (2017)
Ito, Matthew K.; Santos, Raul D.
Source: The Journal of Clinical Pharmacology. Unidade: FM
Subjects: LIPÍDEOS, ANTICORPOS MONOCLONAIS, HIPERCOLESTEROLEMIA, DOENÇAS GENÉTICAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ITO, Matthew K. e SANTOS, Raul D. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, v. 57, n. 1, p. 7-32, 2017Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf. Acesso em: 16 nov. 2024.
APA
Ito, M. K., & Santos, R. D. (2017). PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia. The Journal of Clinical Pharmacology, 57( 1), 7-32. doi:10.1002/jcph.766
NLM
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.[citado 2024 nov. 16 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Vancouver
Ito MK, Santos RD. PCSK9 Inhibition With Monoclonal Antibodies: Modern Management of Hypercholesterolemia [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 1): 7-32.[citado 2024 nov. 16 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/jcph.766/epdf
Artigo de periodico
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial (2017)
Prince, H. Miles; Kim, Youn H.; Horwitz, Steven M.; Dummer, Reinhard; Scarisbrick, Julia; Quaglino, Pietro; Zinzani, Pier Luigi; Wolter, Pascal; Sanches, Jose A.; Ortiz-Romero, Pablo L.; Akilov, Oleg E.; Geskin, Larisa; Trotman, Judith; Taylor, Kerry; Dalle, Stephane; Weichenthal, Michael; Walewski, Jan; Fisher, David; Dréno, Brigitte; Stadler, Rudolf; Feldman, Tatyana; MKuzel, Timothy; Wang, Yinghui; Palanca-Wessels, Maria Corinna; Zagadailov, Erin; Trepicchio, William L; Zhang, Wenwen; Lin, Hui-Min; Liu, Yi; Huebner, Dirk; Little, Meredith; Whittaker, Sean; Duvic, Madeleine
Source: Lancet. Unidade: FM
Subjects: LINFOMA, ESTRATÉGIAS TERAPÊUTICAS, ANTINEOPLÁSICOS, MANIFESTAÇÕES CUTÂNEAS, PROGNÓSTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PRINCE, H. Miles et al. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet, v. 390, n. 10094, p. 555-566, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)31266-7. Acesso em: 16 nov. 2024.
APA
Prince, H. M., Kim, Y. H., Horwitz, S. M., Dummer, R., Scarisbrick, J., Quaglino, P., et al. (2017). Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial. Lancet, 390( 10094), 555-566. doi:10.1016/S0140-6736(17)31266-7
NLM
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, MKuzel T, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin H-M, Liu Y, Huebner D, Little M, Whittaker S, Duvic M. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial [Internet]. Lancet. 2017 ; 390( 10094): 555-566.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)31266-7
Vancouver
Prince HM, Kim YH, Horwitz SM, Dummer R, Scarisbrick J, Quaglino P, Zinzani PL, Wolter P, Sanches JA, Ortiz-Romero PL, Akilov OE, Geskin L, Trotman J, Taylor K, Dalle S, Weichenthal M, Walewski J, Fisher D, Dréno B, Stadler R, Feldman T, MKuzel T, Wang Y, Palanca-Wessels MC, Zagadailov E, Trepicchio WL, Zhang W, Lin H-M, Liu Y, Huebner D, Little M, Whittaker S, Duvic M. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial [Internet]. Lancet. 2017 ; 390( 10094): 555-566.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)31266-7
Artigo de periodico
Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens (2017)
Corral, M. A.; Paula, F. M.; Meisel, D. M. C. L.; Castilho, V. L. P.; Gonçalves, E. M. N.; Levy, D.; Bydlowski, S. P.; Chieffi, P. P.; Castro-Borges, W.; Gryschel, R. C. B.
Source: Parasitology. Unidade: FM
Subjects: ELISA, TESTES IMUNOLÓGICOS, STRONGYLIDA, INFECÇÕES POR STRONGYLIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRAL, M. A. et al. Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens. Parasitology, v. 144, n. 2, p. 124-130, 2017Tradução . . Disponível em: https://doi.org/10.1017/S0031182016001645. Acesso em: 16 nov. 2024.
APA
Corral, M. A., Paula, F. M., Meisel, D. M. C. L., Castilho, V. L. P., Gonçalves, E. M. N., Levy, D., et al. (2017). Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens. Parasitology, 144( 2), 124-130. doi:10.1017/S0031182016001645
NLM
Corral MA, Paula FM, Meisel DMCL, Castilho VLP, Gonçalves EMN, Levy D, Bydlowski SP, Chieffi PP, Castro-Borges W, Gryschel RCB. Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens [Internet]. Parasitology. 2017 ; 144( 2): 124-130.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/S0031182016001645
Vancouver
Corral MA, Paula FM, Meisel DMCL, Castilho VLP, Gonçalves EMN, Levy D, Bydlowski SP, Chieffi PP, Castro-Borges W, Gryschel RCB. Potential immunological markers for diagnosis of human strongyloidiasis using heterologous antigens [Internet]. Parasitology. 2017 ; 144( 2): 124-130.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/S0031182016001645
Artigo de periodico
Anterolateral Ligament of the Fetal Knee: An Anatomic and Histological Study (2017)
Helito, Camilo Partezani; Torres, Julio Augusto do Prado; Bonadio, Marcelo Batista; Aragão, José Aderval; Oliveira Lucas Nogueira de; Natalino, Renato José Mendonça; Pécora, José Ricardo; Camanho, Gilberto Luis; Demange, Marco Kawamura
Source: American Journal of Sports Medicine. Unidade: FM
Subjects: JOELHO, LIGAMENTOS ARTICULARES, FETO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HELITO, Camilo Partezani et al. Anterolateral Ligament of the Fetal Knee: An Anatomic and Histological Study. American Journal of Sports Medicine, n. 1, p. 91-96, 2017Tradução . . Disponível em: https://doi.org/10.1177/0363546516664888. Acesso em: 16 nov. 2024.
APA
Helito, C. P., Torres, J. A. do P., Bonadio, M. B., Aragão, J. A., Oliveira Lucas Nogueira de,, Natalino, R. J. M., et al. (2017). Anterolateral Ligament of the Fetal Knee: An Anatomic and Histological Study. American Journal of Sports Medicine, ( 1), 91-96. doi:10.1177/0363546516664888
NLM
Helito CP, Torres JA do P, Bonadio MB, Aragão JA, Oliveira Lucas Nogueira de, Natalino RJM, Pécora JR, Camanho GL, Demange MK. Anterolateral Ligament of the Fetal Knee: An Anatomic and Histological Study [Internet]. American Journal of Sports Medicine. 2017 ;( 1): 91-96.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/0363546516664888
Vancouver
Helito CP, Torres JA do P, Bonadio MB, Aragão JA, Oliveira Lucas Nogueira de, Natalino RJM, Pécora JR, Camanho GL, Demange MK. Anterolateral Ligament of the Fetal Knee: An Anatomic and Histological Study [Internet]. American Journal of Sports Medicine. 2017 ;( 1): 91-96.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1177/0363546516664888
Artigo de periodico
Brazilian borreliosis with special emphasis on humans and horses (2017)
Basile, Roberta Carvalho; Yoshinari, Natalino Hajime; Mantovani, Elenice; Bonoldi, Virgínia Nazário; Macoris, Delphim da Graça; Queiroz-Neto, Antonio de
Source: Brazilian Journal of Microbiology. Unidade: FM
Subjects: RECIDIVA, ZOONOSES, DOENÇAS NEGLIGENCIADAS, BORRELIOSES ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASILE, Roberta Carvalho et al. Brazilian borreliosis with special emphasis on humans and horses. Brazilian Journal of Microbiology, v. 48, n. 1, p. 167-172, 2017Tradução . . Disponível em: http://www.scielo.br/pdf/bjm/v48n1/1517-8382-bjm-48-01-0167.pdf. Acesso em: 16 nov. 2024.
APA
Basile, R. C., Yoshinari, N. H., Mantovani, E., Bonoldi, V. N., Macoris, D. da G., & Queiroz-Neto, A. de. (2017). Brazilian borreliosis with special emphasis on humans and horses. Brazilian Journal of Microbiology, 48( 1), 167-172. doi:10.1016/j.bjm.2016.09.005
NLM
Basile RC, Yoshinari NH, Mantovani E, Bonoldi VN, Macoris D da G, Queiroz-Neto A de. Brazilian borreliosis with special emphasis on humans and horses [Internet]. Brazilian Journal of Microbiology. 2017 ; 48( 1): 167-172.[citado 2024 nov. 16 ] Available from: http://www.scielo.br/pdf/bjm/v48n1/1517-8382-bjm-48-01-0167.pdf
Vancouver
Basile RC, Yoshinari NH, Mantovani E, Bonoldi VN, Macoris D da G, Queiroz-Neto A de. Brazilian borreliosis with special emphasis on humans and horses [Internet]. Brazilian Journal of Microbiology. 2017 ; 48( 1): 167-172.[citado 2024 nov. 16 ] Available from: http://www.scielo.br/pdf/bjm/v48n1/1517-8382-bjm-48-01-0167.pdf
Artigo de periodico
Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, FMRP
Subjects: PROMOÇÃO DA SAÚDE, ACORDOS INTERNACIONAIS, DESENVOLVIMENTO SUSTENTÁVEL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1423-1459, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32336-X. Acesso em: 16 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1423-1459. doi:10.1016/S0140-6736(17)32336-X
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1423-1459.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)32336-X
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1423-1459.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)32336-X
Artigo de periodico
Importância dos achados clínicos e laboratoriais no diagnóstico e prognóstico cirúrgico de pacientes com pericardite constritiva (2017)
Fernandes, Fábio; Melo, Dirceu Thiago Pessoa de; Ramires, Felix José Alvarez; Dias, Ricardo Ribeiro; Tonini, Marcio; Fernandes, Vinicius dos Santos; Rochitte, Carlos Eduardo; Moreira, Carlos Henrique Valente; Mady, Charles
Source: Arquivos Brasileiros de Cardiologia. Unidade: FM
Subjects: PERICARDITE, CUSTOS DE MEDICAMENTOS, PROGNÓSTICO, DIAGNÓSTICO POR IMAGEM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Fábio et al. Importância dos achados clínicos e laboratoriais no diagnóstico e prognóstico cirúrgico de pacientes com pericardite constritiva. Arquivos Brasileiros de Cardiologia, v. 109, n. 5, p. 457-465, 2017Tradução . . Disponível em: https://doi.org/10.5935/abc.20170147. Acesso em: 16 nov. 2024.
APA
Fernandes, F., Melo, D. T. P. de, Ramires, F. J. A., Dias, R. R., Tonini, M., Fernandes, V. dos S., et al. (2017). Importância dos achados clínicos e laboratoriais no diagnóstico e prognóstico cirúrgico de pacientes com pericardite constritiva. Arquivos Brasileiros de Cardiologia, 109( 5), 457-465. doi:10.5935/abc.20170147
NLM
Fernandes F, Melo DTP de, Ramires FJA, Dias RR, Tonini M, Fernandes V dos S, Rochitte CE, Moreira CHV, Mady C. Importância dos achados clínicos e laboratoriais no diagnóstico e prognóstico cirúrgico de pacientes com pericardite constritiva [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 109( 5): 457-465.[citado 2024 nov. 16 ] Available from: https://doi.org/10.5935/abc.20170147
Vancouver
Fernandes F, Melo DTP de, Ramires FJA, Dias RR, Tonini M, Fernandes V dos S, Rochitte CE, Moreira CHV, Mady C. Importância dos achados clínicos e laboratoriais no diagnóstico e prognóstico cirúrgico de pacientes com pericardite constritiva [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 109( 5): 457-465.[citado 2024 nov. 16 ] Available from: https://doi.org/10.5935/abc.20170147
Artigo de periodico
Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV (2017)
Noble, Caroline Furtado; Malta, Fernanda; Lisboa-Neto, Gaspar; Gomes-Gouvêa, Michele Soares; Leite, Andrea Gurgel Batista; Castro, Vanessa Fusco Duarte de; Santana, Rubia Anita Ferraz; Carrilho, Flair José; Mendes-Correa, Maria Cássia; Pinho, João Renato Rebello
Source: Archives of Virology. Unidade: FM
Subjects: BRASILEIROS, HIV, HEPATITE C, INFECÇÕES OPORTUNISTAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NOBLE, Caroline Furtado et al. Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV. Archives of Virology, v. 162, n. 1, p. 165-169, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00705-016-3094-2. Acesso em: 16 nov. 2024.
APA
Noble, C. F., Malta, F., Lisboa-Neto, G., Gomes-Gouvêa, M. S., Leite, A. G. B., Castro, V. F. D. de, et al. (2017). Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV. Archives of Virology, 162( 1), 165-169. doi:10.1007/s00705-016-3094-2
NLM
Noble CF, Malta F, Lisboa-Neto G, Gomes-Gouvêa MS, Leite AGB, Castro VFD de, Santana RAF, Carrilho FJ, Mendes-Correa MC, Pinho JRR. Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV [Internet]. Archives of Virology. 2017 ; 162( 1): 165-169.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00705-016-3094-2
Vancouver
Noble CF, Malta F, Lisboa-Neto G, Gomes-Gouvêa MS, Leite AGB, Castro VFD de, Santana RAF, Carrilho FJ, Mendes-Correa MC, Pinho JRR. Natural occurrence of NS5B inhibitor resistance-associated variants in Brazilian patients infected with HCV or HCV and HIV [Internet]. Archives of Virology. 2017 ; 162( 1): 165-169.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1007/s00705-016-3094-2
Artigo de periodico
Endolymphatic sac drainage for the treatment of Ménière's disease (2017)
Bento, R. F.; Cisneros, J. C.; Fonseca, A. C. De Oliveira
Source: Journal of Laryngology and Otology. Unidade: FM
Subjects: DRENAGEM, PERDA AUDITIVA, VERTIGEM, PROCEDIMENTOS CIRÚRGICOS OTOLÓGICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BENTO, R. F. e CISNEROS, J. C. e FONSECA, A. C. De Oliveira. Endolymphatic sac drainage for the treatment of Ménière's disease. Journal of Laryngology and Otology, v. 131, n. 2, p. 144-149, 2017Tradução . . Disponível em: https://doi.org/10.1017/S0022215116009713. Acesso em: 16 nov. 2024.
APA
Bento, R. F., Cisneros, J. C., & Fonseca, A. C. D. O. (2017). Endolymphatic sac drainage for the treatment of Ménière's disease. Journal of Laryngology and Otology, 131( 2), 144-149. doi:10.1017/S0022215116009713
NLM
Bento RF, Cisneros JC, Fonseca ACDO. Endolymphatic sac drainage for the treatment of Ménière's disease [Internet]. Journal of Laryngology and Otology. 2017 ; 131( 2): 144-149.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/S0022215116009713
Vancouver
Bento RF, Cisneros JC, Fonseca ACDO. Endolymphatic sac drainage for the treatment of Ménière's disease [Internet]. Journal of Laryngology and Otology. 2017 ; 131( 2): 144-149.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1017/S0022215116009713
Artigo de periodico
Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 (2017)
Reitsma, Marissa B.; Santos, Itamar de Souza; Bensenor Isabela M.
Source: Lancet. Unidade: FM
Subjects: FATORES DE RISCO, PREVALÊNCIA, DOENÇAS CARDIOVASCULARES, TABAGISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REITSMA, Marissa B. e SANTOS, Itamar de Souza e BENSENOR ISABELA M.,. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, v. 389, n. 10082, p. 1885-1906, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)30819-X. Acesso em: 16 nov. 2024.
APA
Reitsma, M. B., Santos, I. de S., & Bensenor Isabela M.,. (2017). Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet, 389( 10082), 1885-1906. doi:10.1016/S0140-6736(17)30819-X
NLM
Reitsma MB, Santos I de S, Bensenor Isabela M. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 389( 10082): 1885-1906.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)30819-X
Vancouver
Reitsma MB, Santos I de S, Bensenor Isabela M. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015 [Internet]. Lancet. 2017 ; 389( 10082): 1885-1906.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)30819-X
Artigo de periodico
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Goulart, Alessandra Carvalho; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, HU, FMRP
Subjects: CONTROLE DE DOENÇAS NÃO TRANSMISSÍVEIS, MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, SAÚDE PÚBLICA, CONTROLE DE DOENÇAS TRANSMISSÍVEIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1211-1259, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32154-2. Acesso em: 16 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., Goulart, A. C., & Furtado, J. M. F. (2017). Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1211-1259. doi:10.1016/S0140-6736(17)32154-2
NLM
Lotufo PA, Benseñor IJM, Goulart AC, Furtado JMF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1211-1259.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)32154-2
Vancouver
Lotufo PA, Benseñor IJM, Goulart AC, Furtado JMF. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1211-1259.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)32154-2
Artigo de periodico
Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, FMRP
Subjects: FATORES SOCIOECONÔMICOS, MORTALIDADE, EPIDEMIOLOGIA ANALÍTICA, SAÚDE PÚBLICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, v. 390, n. 10100, p. 1260-1344, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)32130-X. Acesso em: 16 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 390( 10100), 1260-1344. doi:10.1016/S0140-6736(17)32130-X
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1260-1344.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)32130-X
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 [Internet]. Lancet. 2017 ; 390( 10100): 1260-1344.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)32130-X
Artigo de periodico
Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article (2017)
Lotufo, Paulo A.; Benseñor, Isabela Judith Martins; Furtado, João Marcello Fortes
Source: Lancet. Unidades: FM, FMRP
Subjects: ANÁLISE GLOBAL, MORTALIDADE INFANTIL, FATORES DE RISCO, EXPECTATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. e BENSEÑOR, Isabela Judith Martins e FURTADO, João Marcello Fortes. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article. Lancet, v. 390, n. 10100, p. 1084-1150, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(17)31833-0. Acesso em: 16 nov. 2024.
APA
Lotufo, P. A., Benseñor, I. J. M., & Furtado, J. M. F. (2017). Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article. Lancet, 390( 10100), 1084-1150. doi:10.1016/S0140-6736(17)31833-0
NLM
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article [Internet]. Lancet. 2017 ; 390( 10100): 1084-1150.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)31833-0
Vancouver
Lotufo PA, Benseñor IJM, Furtado JMF. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016 Open access, Research article [Internet]. Lancet. 2017 ; 390( 10100): 1084-1150.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(17)31833-0
Artigo de periodico
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants (2017)
Lotufo, Paulo A.
Source: Lancet. Unidade: FM
Subjects: FATORES DE RISCO, PREVALÊNCIA, DOENÇAS CARDIOVASCULARES, HIPERTENSÃO, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LOTUFO, Paulo A. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, v. 389, n. 10064, p. 37-55, 2017Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(16)31919-5. Acesso em: 16 nov. 2024.
APA
Lotufo, P. A. (2017). Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet, 389( 10064), 37-55. doi:10.1016/S0140-6736(16)31919-5
NLM
Lotufo PA. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants [Internet]. Lancet. 2017 ; 389( 10064): 37-55.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(16)31919-5
Vancouver
Lotufo PA. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants [Internet]. Lancet. 2017 ; 389( 10064): 37-55.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/S0140-6736(16)31919-5
Artigo de periodico
Periprostatic innervation: New issues based on segmental analysis of 10 human cadaver pelvic blocs (2017)
Rodrigues, Tiago M.; Mitre, Anuar I.; Silva, Luiz Fernando F. da; Castilho, Lísias N.; Simões, Fabiano A.; Saldiva, Paulo Hilário Nascimento ; Srougi, Miguel
Source: Prostate. Unidade: FM
Subjects: FIBRAS NERVOSAS, PRÓSTATA, PROSTATECTOMIA, DISFUNÇÃO SEXUAL FISIOLÓGICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RODRIGUES, Tiago M. et al. Periprostatic innervation: New issues based on segmental analysis of 10 human cadaver pelvic blocs. Prostate, v. 77, n. 10, p. 1151-1159, 2017Tradução . . Disponível em: https://doi.org/10.1002/pros.23374. Acesso em: 16 nov. 2024.
APA
Rodrigues, T. M., Mitre, A. I., Silva, L. F. F. da, Castilho, L. N., Simões, F. A., Saldiva, P. H. N., & Srougi, M. (2017). Periprostatic innervation: New issues based on segmental analysis of 10 human cadaver pelvic blocs. Prostate, 77( 10), 1151-1159. doi:10.1002/pros.23374
NLM
Rodrigues TM, Mitre AI, Silva LFF da, Castilho LN, Simões FA, Saldiva PHN, Srougi M. Periprostatic innervation: New issues based on segmental analysis of 10 human cadaver pelvic blocs [Internet]. Prostate. 2017 ; 77( 10): 1151-1159.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/pros.23374
Vancouver
Rodrigues TM, Mitre AI, Silva LFF da, Castilho LN, Simões FA, Saldiva PHN, Srougi M. Periprostatic innervation: New issues based on segmental analysis of 10 human cadaver pelvic blocs [Internet]. Prostate. 2017 ; 77( 10): 1151-1159.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1002/pros.23374

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration